First human Phase 1 data for AI-designed ISM6331 to be presented
Insilico Medicine plans to present first human Phase 1 data for the AI-designed pan-TEAD inhibitor ISM6331 in mesothelioma and other ...
Insilico Medicine plans to present first human Phase 1 data for the AI-designed pan-TEAD inhibitor ISM6331 in mesothelioma and other ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine